This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bayer to Lay Out $14.2 Billion for Merck's Consumer Care Business


WATCH: More market update videos on TheStreet TV | More videos from Brittany Umar

NEW YORK (TheStreet) -- German drugmaker Bayer said it would buy Merck's consumer care business, including brands like Claritin and Coppertone, for $14.2 billion.

VIDEO TRANSCRIPT:

German drugmaker Bayer said it would buy Merck's (MRK) consumer care business for $14.2 billion.

The deal is set to make Bayer the second-biggest over-the-counter drug-maker behind Johnson & Johnson (JNJ).  According to the company, it should add $2.2 billion in annual sales to its non-prescription business.

Merck said it expects after-tax proceeds of between $8 billion and $9 billion from the deal.  It said it plans to use the proceeds to develop products that have the highest potential growth opportunities. The deal is expected to close in the second half of 2014.

It is the latest in a string of M&A activity within the drug space.  Last month, Novartis (NVS), GlaxoSmithKline (GSK) and Eli Lilly (LLY) announced a $28.5 billion deal while Pfizer (PFE) has been seeking a $106 billion takeover of AstraZeneca (AZN).

At last check, shares of Merck were falling about 1.7% to $57.64.

In New York, I'm Brittany Umar for TheStreet.

-- Written by Brittany Umar in New York.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%
YHOO $44.52 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs